At a glance
ClinicalIndex Comparison RecordN/ACompleted· 28 enrolled
Drug / intervention
Viasys® Healthcare, Pulmonetic Systems, lap-top ventilator (LTV machine)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized Crossover Study of Standard, Noninvasive Positive Pressure Ventilation (NIPPV) and Low Expiratory Pressure NIPPV in Amyotrophic Lateral Sclerosis (ALS) Patients
In Brief
A clinical study evaluating Viasys® Healthcare, Pulmonetic Systems, lap-top ventilator (LTV machine) for Amyotrophic Lateral Sclerosis. Completed, enrolled 28 participants across 1 site.
Detailed Summary
The purpose of the study is to test whether noninvasive positive pressure ventilation (NIPPV) without expiratory positive airway pressure (EPAP) (inspiratory positive airway pressure (IPAP)-only) will result in an increase in patient usage of NIPPV compared with standard, Bi-level NIPPV. Secondarily, the investigators will assess measures of dyspnea, quality of life, patient satisfaction, and side effects.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAmyotrophic Lateral Sclerosis
CountriesUnited States
CollaboratorsALS Association
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJan 2008
First PostedJun 2010
Primary CompletionOct 2011
TodayJul 2026
First PostedJun 30, 2010
Enrollment StartJan 1, 2008
Primary CompletionOct 1, 2011
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 16.0 years ago
Interventions
Viasys® Healthcare, Pulmonetic Systems, lap-top ventilator (LTV machine)device
Noninvasive positive airway pressure ventilation